Central-line associated bloodstream infections in a tertiary care children's University hospital: a prospective study

Elisabetta Venturini1, Carlotta Montagnani1, Alessandra Benni1

  • 1Department of Health Sciences, University of Florence, Meyer Children's University Hospital, Florence, Italy.

BMC Infectious Diseases
|December 2, 2016
PubMed

Insights

Central-line associated bloodstream infections (CLABSI) are common in children. This study found higher CLABSI rates in females and children with underlying conditions, highlighting the spread of multi-resistant pathogens.

Area of Science:

  • Pediatric Infectious Diseases
  • Healthcare Epidemiology
  • Clinical Microbiology

Background:

  • Central-line associated bloodstream infections (CLABSI) are the most frequent healthcare-associated infections in pediatric populations.
  • There is a need for high-quality, large-scale studies on CLABSI in children, particularly in diverse healthcare settings.
  • This prospective study addresses this gap by monitoring CLABSI across all departments of an Italian tertiary care children's hospital.

Purpose of the Study:

  • To prospectively investigate the incidence and risk factors of central-line associated bloodstream infections (CLABSI) in children admitted to a tertiary care hospital.
  • To identify specific patient demographics and underlying conditions associated with an increased risk of CLABSI.
  • To characterize the microbial pathogens, including multi-resistant organisms, causing CLABSI in this pediatric cohort.

Main Methods:

  • A 6-month prospective surveillance of CLABSI in all pediatric patients (<18 years) with central line access at Meyer Children's University Hospital, Florence, Italy.
  • CLABSI cases were identified using the Centers for Disease Control and Prevention criteria.
  • Incidence rates, relative risks, and confidence intervals were calculated, with statistical significance set at p < 0.05.

Main Results:

  • The overall CLABSI incidence rate was 3.73 per 1000 central line-days (95% CI: 2.54-5.28).
  • Higher CLABSI incidence was observed in female patients (p=0.045) and those with underlying medical conditions (p=0.06), excluding prematurity, surgical diseases, and malignancy.
  • Five infections were caused by extended-spectrum β-lactamase (ESBL) producing organisms, and one by carbapenem-resistant Klebsiella pneumoniae.

Conclusions:

  • The study confirms the increasing prevalence of multi-resistant pathogens causing healthcare-associated infections in children.
  • Underlying medical conditions were identified as a significant factor associated with increased CLABSI rates in pediatric patients.
  • Further pediatric research is recommended to better understand CLABSI risk factors and develop targeted intervention strategies.
Abstract

Related Concept Videos